Oxytocin Market Expected to Reach $193.02 Million by 2032, Growing at a CAGR of 9.3%

Market Overview:

The global oxytocin market size is expected to reach USD 193.02 million by 2032, exhibiting a CAGR of 9.3% during the forecast period.

What is Oxytocin?

Oxytocin is an organic hormone that handles crucial details of female and male reproductive systems involving labor and delivery and lactation as well as facets of human bearing. The hypothalamus makes oxytocin, but the rearward pituitary gland preserves and releases it into the bloodstream. Hormones are chemicals that correlate varied functions in the body by conveying messages via the blood to the organs, muscles, and alternate tissues. These indications notify the body what to do and when to do it. The hypothalamus is that segment of the brain that regulates functions such as blood pressure, heart rate, body temperature, and digestion.

Download Free Sample PDF Copy of the Report:

https://www.polarismarketresearch.com/industry-analysis/oxytocin-market/request-for-sample

Major Participants

Some of the major players in the oxytocin market include:

• Pfizer Inc.
• Novartis AG
• Ferring B.V.
• Fresenius Kabi LLC
• Hikma Pharmaceuticals PLC
• Endo International plc. (Par Sterile Products, LLC)
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Wockhardt Ltd.
• Sun Pharmaceutical Industries Ltd.
• Yuhan Corporation

Growth Prospects and Trends

Teenage pregnancy and birth rates in the US transcend those of any other advanced nation. Reducing birth rates and growing life expectancy have caused a worldwide demographic shift, changing the age scattering of populations.

Moreover, in 2020, one woman strayed her life every 2 minutes because of avoidable genesis linked with pregnancy. This compares to approximately 800 women per day, a maternal mortality ratio of 223 maternal loss of life per 100,000 live births. Amidst 2016 and 2020, maternal mortality ratios stayed motionless in 133 countries while sizeably escalating in 17 nations.

Regional Insights

Oxytocin Market, Regional Outlook (Revenue – USD Million, 2019-2032)

• North America
  • Indication Outlook
    • Antepartum
    • Postpartum
  • Distribution Channel Outlook
    • Hospital Pharmacies
    • Drug Stores
    • Online Pharmacies
• Europe
  • Indication Outlook
    • Antepartum
    • Postpartum
  • Distribution Channel Outlook
    • Hospital Pharmacies
    • Drug Stores
    • Online Pharmacies

• North America makes up the majority of the market. This is primarily because escalating aggregate of pre-term births, fertility rates, and enhanced healthcare disbursements. In the course of the antepartum period, oxytocin helps reinforce uterine shrinkage focusing on the triumphant vaginal delivery of the fetus.

• Throughout the projection period, it is expected that the APAC market will grow at a faster CAGR. This results from escalated consciousness of maternal health, growing childbirth costs, and progression in healthcare frameworks. 

Recent Developments in the Industry:

• July 2023 – Endo International & Premier:
  Endo International partnered with Premier to address the shortage of Pitocin (oxytocin injection), a crucial medication used to induce labor in pregnant women. This collaboration aims to alleviate the supply issues and ensure continued availability of this essential drug.
• October 2023 – Tonix Pharmaceuticals:
  Tonix Pharmaceuticals announced that the European Union (EU) had granted a patent for the use of intranasal potentiated oxytocin (TNX-1900) in pain management. This development opens new therapeutic possibilities for oxytocin in treating pain, further expanding its clinical applications.

The market is experiencing growth driven by increasing initiatives in maternal healthcare, which prioritize safe and effective obstetric care. Oxytocin, essential for labor induction and managing postpartum haemorrhage, plays a pivotal role in maternal healthcare. Efforts to decrease maternal mortality rates, enhance access to quality healthcare, and improve obstetric practices contribute to the rising demand for oxytocin injections. Additionally, endeavors to ensure the availability of essential medicines in maternal health programs are propelling the market, underscoring oxytocin’s crucial role in enhancing maternal outcomes and overall obstetric care, particularly in regions facing significant maternal healthcare challenges.